CD28 and colorectal cancer: For instance, miR-424 carried by colorectal cancer (CRC)-derived EVs downregulates the expression of CD28 in T cells, thereby attenuating the CD28-CD80/86 costimulatory pathway and inhibiting T cell activation to facilitate immune evasion [93].